PDF下载 ( 155 KB)
Interactions of nonalcoholic fatty liver disease with metabolic syndrome and chronic viral hepatitis: an emphasis on Taiwan experience sharing
-
-
[1]Sanyal AJ.American Gastroenterological Association.AGA technical review on nonalcoholic fatty liver disease[J].Gastroenterology, 2002, 123 (5) :1705-1725. [2]American Gastroenterological Association Medical Position Statement:Nonalcoholic fatty liver disease[J].Gastroenterology, 2002, 123 (5) :1702-1704. [3]Angulo P.Nonalcoholic fatty liver disease[J].N Engl J Med, 2002, 346 (16) :1221-1231. [4]Bugianesi E, Leone N, Vanni E, et al.Expanding the natural histo-ry of nonalcoholic steatohepatitis:from cryptogenic cirrhosis to hepa-tocellular carcinoma[J].Gastroenterology, 2002, 123 (1) :134-140. [5]Caldwell SH, Oelsner DH, Iezzoni JC, et al.Cryptogenic cirrhosis:clinical characterization and risk factors for underlying disease[J].Hepatology, 1999, 29 (3) :664-669. [6]Kumar KS, Malet PF.Nonalcoholic steatohepatitis[J].Mayo Clin Proc, 2000, 75 (7) :733-739. [7]Neuschwander-Tetri BA.Nonalcoholic steatohepatitis:Summary of an AASLD single topic conference[J].Hepatology, 2003, 37 (5) :1202-1219. [8]Reid AE.Nonalcoholic steatohepatiits[J].Gastroenterology, 2001, 121 (3) :710-723. [9]Farrell GC.Nonalcoholic fatty liver disease:from steatosis to cirrho-sis[J].Hepatology, 2006, 43 (2suppl1) :S99-S112. [10]Falck-Ytter Y, Younossi ZM, Marchesini G, et al.Clinical fea-tures and natural history of nonalcoholic steatosis syndromes[J].Se-min Liver Dis, 2001, 21 (1) :17-26. [11]Ruhl CE, Everhart JE.Determinants of the association of over-weight with elevated serum alanine aminotransferase activity in the U-nited States[J].Gastroenterology, 2003, 124 (1) :71-79. [12]Youssef W, McCullough AJ.Diabetes mellitus, obesity, and hepat-ic steatosis[J].Semin Gastrointest Dis, 2002, 13 (1) :17-30. [13]Chang HY, Yeh WT, Chang YH, et al.Prevalence of dyslipidemia and mean blood lipid values in Taiwan:results fromthe Nutrition andHealth Survey in Taiwan (NAHSIT, 1993-1996) [J].Chin J Physiol, 2002, 45 (4) :187-197. [14]Lin YC, Yen LL, Chen SY, et al.Prevalence of overweight and o-besity and its associated factors:findings from National Nutrition and Health Survey in Taiwan, 1993-1996[J].Prev Med, 2003, 37 (3) :233-241. [15]Pan WH, Chang HY, Yeh WT, et al.Prevalence, awareness, treat-ment and control of hypertension in Taiwan:results of Nutrition and Health Survey in Taiwan (NAHSIT) 1993-1996[J].J Hum Hy-pertens, 2001, 15 (11) :793-798. [16]WEI JN, SUNG FC, LIN CC et al.National surveillance for type II diabetes mellitus in Taiwanese children[J].JAMA, 2003, 290 (10) :1345-1350. [17]Hwang LC, Bai CH, Chen CJ.Prevalence of obesity and metabolic syndrome in Taiwan[J].J Formos Med Assoc, 2006, 105 (8) :626-635. [18]Brunt EM.Nonalcoholic steatohepatitis:Definition and pathology[J].Semin Liver Dis, 2001, 21 (1) :3-16. [19]Ludwig J, Viggiano TR, McGill DB, et al.Nonalcoholic steatohepa-titis:Mayo Clinic experiences with a hitherto unnamed disease[J].Mayo Clin Proc, 1980, 55 (7) :434-438. [20]Wanless IR, Lentz JS.Fatty liver hepatitis (steatohepatitis) and o-besity:an autopsy study with analysis of risk factors[J].Hepatolo-gy, 1990, 12 (5) :1106-1110. [21]Baldridge AD, Perez-Atayde AR, Graeme-Cook F, et al.Idio-pathic steatohepatitis in childhood:a multicenter retrospective study[J].J Pediatr, 1995, 127 (5) :700-704. [22]Kinugasa A, Tsunamoto K, Furukawa N, et al.Fatty liver and its fi-brous changes found in simple obesity of children[J].J Pediatr Gas-troenterol Nutr, 1984, 3 (3) :408-414. [23]Fan JG, Zhu J, Li XJ, et al.Fatty liver and the metabolic syn-drome among Shanghai adults[J].J Gastroenterol Hepatol, 2005, 20 (12) :1825-1832. [24]Park SH, Jeon WK, Kim SH, et al.Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults[J].J Gastro-enterol Hepatol, 2006, 21 (1Pt1) :138-143. [25]Park SH, Kim BI, Yun JW, et al.Insulin resistance and C-reac-tive protein as independent risk factors for non-alcoholic fatty liver disease in non-obese Asian men[J].J Gastroenterol Hepatol, 2004, 19 (6) :694-698. [26]Farrell GC.Non-alcoholic steatohepatitis:what is it, and why is it important in the Asia-Pacific region-[J]J Gastroenterol Hepatol, 2003, 18 (2) :124-138. [27]Chen CH, Huang MH, Yang JC, et al.Prevalence and risk factors of nonalcoholic fatty liver disease in an adult population of Taiwan:metabolic significance of nonalcoholic fatty liver disease in nonobese adults[J].J Clin Gastroenterol, 2006, 40 (8) :745-752. [28]Wong VW, Hui AY, Tsang SW, et al.Metabolic and adipokine pro-file of Chinese patients with nonalcoholic fatty liver disease[J].Clin Gastroenterol Hepatol, 2006, 4 (9) :1154-1161. [29]Hasan I, Gani RA, Machmud R, et al.Prevalence and risk factors for nonalcoholic fatty liver in Indonesia[J].J Gastroenterol Hepatol, 2002, 17 (Suppl) :S154. [30]Leung NW.Epidemiological study:nonalcoholic fatty liver disease in Hong Kong Chinese[J].Hepatology, 2004, 40 (Suppl1) :582A. [31]Duseja A, Chawla Y.Nonalcoholic fatty liver disease in India--How much-Howsoon-[J].Trop Gastoenterol, 2005, 26 (1) :1-3. [32]Malik A, Cheah PL, Hilmi IN, et al.Non-alcoholic fatty liver dis-ease in Malaysia:A demographic, anthropometric, metabolic and histological study[J].J Dig Dis, 2007, 8 (1) :58-64. [33]Agarwal SR, Malhotra V, Sakhuja P, et al.Clinical biochemical and histological profile of nonalcoholic steatohepatitis[J].Indian J Gas-troenterol, 2001, 20 (5) :183-186. [34]Nomura H, Kashiwagi S, Hayashi J, et al.Prevalence of fatty liver in a general population of Okinawa, Japan[J].Jpn J Med, 1988, 27 (2) :142-149. [35]Oshibuchi M, Nishi F, Sato M, et al.Frequency of abnormalities detected by abdominal ultrasound among Japanese adults[J].J Gas-troenterol Hepatol, 1991, 6 (2) :165-168. [36]Ikai E, Ishizaki M, Suzuki Y, et al.Association between hepatic steatosis, insulin resistance and hyperinsulinaemia as related to hy-pertension in alcohol consumers and obese people[J].J HumHyper-tens, 1995, 9 (2) :101-105. [37]Omagari K, Kadokawa Y, Masuda J, et al.Fatty liver in non-al-coholic non-overweight Japanese adults:Incidence and clinical characteristics[J].J Gastroenterol Hepatol, 2002, 17 (10) :1098-105. [38]Lai SW, Tan CK, Ng KC, et al.Epidemiology of fatty liver in a hospital-based study in Taiwan[J].South Med J, 2002, 95 (11) :1288-1292. [39]Lin YD, Lo HM, Chen DJ.Sonographic fatty liver, overweight and ischemic heart disease[J].World J Gastroenterol, 2005, 11 (31) :4838-4842. [40]Hwang SJ, Luo JC, Chu CW, et al.Hepatic steatosis in chronic hepatitis C virus infection:prevalence and clinical correlation[J].J Gastroenterol Hepatol, 2001, 16 (2) :190-195. [41]Liu CJ, Jeng YM, Chen PJ, et al.Influence of metabolic syndrome, viral genotype and antiviral therapy on superimposed fatty liver dis-ease in chronic hepatitis C[J].Antivir Ther, 2005, 10 (3) :405-415. [42]Liu CJ, Chen PJ, Jeng YM, et al.Serumadiponectin correlates with viral characteristics but not histologic features in patients with chronic hepatitis C[J].J Hepatol, 2005, 43 (2) :235-242. [43]Hsu CS, Liu CJ, Liu CH, et al.High hepatitis C viral load is asso-ciated with insulin resistance in patients with chronic hepatitis C[J].Liver Int, 2008, 28 (2) :271-277. [44]Hsu CS, Liu CJ, Liu CH, et al.Metabolic profiles in patients with chronic hepatitis C:a case-control study[J].Hepatol Int, 2008, 2 (2) :250-257. [45]Hsu CS, Liu CH, Liu CJ, et al.Association of lipid profiles with hepatitis C viral load in chronic hepatitis C patients with genotype1or2infection[J].Am J Gastroenterol, 2009, 104 (3) :598-604. [46]Dai CY, Huang JF, Hsieh MY, et al.Insulin resistance predicts re-sponse to peginterferon-alpha/ribavirin combination therapy in chro-nic hepatitis C patients[J].J Hepatol, 2009, 50 (4) :712-718. [47]Huang JF, Dai CY, Hwang SJ, et al.Hepatitis C viremia increases the association with type2diabetes mellitus in a hepatitis B and C endemic area:an epidemiological link with virological implication[J].Am J Gastroenterol, 2007, 102:1237-1243. [48]Miyanari Y, Atsuzawa K, Usuda N, et al.The lipid droplet is an important organelle for hepatitis C virus production[J].Nature Cell Biol, 2007, 9 (9) :1089-1097. [49]Dai CY, Chuang WL, Ho CK, et al.Associations between hepatitis C viremia and low serum triglyceride and cholesterol levels:a com-munity-based study[J].J Hepatol, 2008, 49 (1) :9-16. [50]Wang CC, Hsu CS, Liu CJ, et al.Association of chronic hepatitis B virus infection with insulin resistance and hepatic steatosis[J].J Gastroenterol Hepatol, 2008, 23 (5) :779-782. [51]Chen CL, Yang HI, Yang WS, et al.Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection:A fol-low-up study in Taiwan[J].Gastroenterology, 2008, 135 (1) :111-121. [52]Yu MW, Shih WL, Lin CL, et al.Body-mass index and progres-sion of hepatitis B:Apopulation-based cohort study in men[J].J Clin Oncol, 2008, 26 (34) :5576-5582. [53]Wong GL, Wong VW, Choi PC, et al.Metabolic syndrome increa-ses the risk of liver cirrhosis in chronic hepatitis B[J].Gut, 2009, 58 (1) :111-117. -
本文二维码
计量
- 文章访问数: 169
- HTML全文浏览量: 8
- PDF下载量: 99
- 被引次数: 0
下载:
